1. Home
  2. FOXF vs IMMX Comparison

FOXF vs IMMX Comparison

Compare FOXF & IMMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fox Factory Holding Corp.

FOXF

Fox Factory Holding Corp.

HOLD

Current Price

$19.94

Market Cap

800.6M

ML Signal

HOLD

Logo Immix Biopharma Inc.

IMMX

Immix Biopharma Inc.

HOLD

Current Price

$12.24

Market Cap

716.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOXF
IMMX
Founded
2007
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Motor Vehicles
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
800.6M
716.2M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
FOXF
IMMX
Price
$19.94
$12.24
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
$30.25
$19.20
AVG Volume (30 Days)
378.3K
1.4M
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,467,321,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$0.90
N/A
P/E Ratio
N/A
N/A
Revenue Growth
5.27
N/A
52 Week Low
$13.08
$1.94
52 Week High
$28.76
$15.10

Technical Indicators

Market Signals
Indicator
FOXF
IMMX
Relative Strength Index (RSI) 44.52 51.84
Support Level $15.62 $7.96
Resistance Level $19.75 $15.10
Average True Range (ATR) 0.74 0.81
MACD -0.25 -0.25
Stochastic Oscillator 19.34 24.76

Price Performance

Historical Comparison
FOXF
IMMX

About FOXF Fox Factory Holding Corp.

Fox Factory Holding Corp is a designer, manufacturer, and marketer of performance-defining products and systems used predominantly on bikes, Side-by-Sides, on-road vehicles with and without off-road capabilities, off-road vehicles and trucks, ATVs, snowmobiles, specialty vehicles and applications, motorcycles, and commercial trucks. Its business operates under the FOX, FOX RACING SHOX, and RACE FACE brands. Geographically, it derives a majority of revenue from North America and also has a presence in Asia, Europe, and the Rest of the World. The company operates in three segments: Powered Vehicles Group, Aftermarket Applications Group, and Specialty Sports Group, of which it derives maximum revenue from Specialty Sports Group segment.

About IMMX Immix Biopharma Inc.

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.

Share on Social Networks: